CSL Broadmeadows Facility Earns 2025 ISPE FOYA Overall Winner Title
CSL's base fractionation facility in Broadmeadows, Australia has been recognised as the Overall Winner of the 2025 Facility of the Year Award (FOYA) by the International Society for Pharmaceutical Engineering (ISPE). Purpose-built to optimise the production of plasma-derived therapies for conditions such as immunodef…
